文献速递关节外科

全膝关节置换术后持续阿片类药物使用:密切监测的信号

Persistent Opioid Use Following Total Knee Arthroplasty: A Signal for Close Surveillance.
PubMed 文献 · J Arthroplasty · 2017-09-13

一项基于整合医疗系统和全关节置换登记处的队列研究纳入24105例因骨关节炎行初次全膝关节置换术的患者,分析术后第一年阿片类药物使用与无菌性翻修手术的关系。术后初始90天后41.5%的患者继续使用阿片类药物,中低至高口服吗啡当量水平患者1年翻修调整风险较未使用阿片类药物者升高,风险比范围为HR=2.4至HR=33。作者认为全膝关节置换术后超过90天仍需阿片类药物的患者需要密切随访。

要点

  • 全膝关节置换术后初始90天后41.5%(N=9914)的患者继续使用阿片类药物。
  • 1年内发生155例(0.6%)翻修,5年内发生377例(1.6%)翻修。
  • 初始90天后使用中低至高口服吗啡当量者1年翻修调整风险较未使用者升高,HR=2.4至HR=33。

核心结论

  • 全膝关节置换术后超过90天仍需阿片类药物的患者需要密切随访。

研究设计与样本

  • 采用整合医疗系统和全关节置换登记处数据,对2008年1月至2011年12月因骨关节炎行初次全膝关节置换术的患者进行队列研究。

主要发现

  • 共研究24105例患者,术后初始90天后41.5%(N=9914)继续使用阿片类药物。
  • 1年内发生155例(0.6%)翻修,5年内发生377例(1.6%)翻修。
  • 与未使用阿片类药物的患者相比,初始90天后使用中低至高口服吗啡当量的患者1年翻修调整风险更高,HR=2.4(95%CI 1.3-4.5)至HR=33(95%CI 10-110),取决于口服吗啡当量和时间段。

关键数值与推荐

  • 术后第一年阿片类药物使用为暴露因素,计算累积每日口服吗啡当量,每90天暴露期总术后口服吗啡当量按四分位数分类。
  • 终点为无菌性翻修手术,风险比调整了年龄、性别、既往镇痛药使用、阿片类药物相关合并症和慢性疼痛诊断。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prolonged opioid use following total knee arthroplasty (TKA) has not been extensively studied. METHODS: A cohort study of primary TKA for osteoarthritis using an integrated healthcare system and Total Joint Replacement Registry (January 2008-December 2011) was conducted. Opioid use during the first year after TKA was the exposure of interest and cumulative daily oral morphine equivalent (OME) amounts were calculated. Total postsurgical OME per 90-day exposure periods were categorized into quartiles. The end point was aseptic revision surgery. Survival analyses were conducted and hazard ratios (HRs) were adjusted for age, gender, prior analgesic use, opioid-related comorbidities, and chronic pain diagnoses. RESULTS: A total of 24,105 patients were studied. After the initial 90-day postoperative period, 41.5% (N = 9914) continued to use opioids. Also, 155 (0.6%) revisions occurred within 1 year and 377 (1.6%) within 5 years. Compared to patients not taking any opioids, patients using medium-low to high OME after the initial 90-day period had a higher adjusted risk of 1-year revision, ranging from HR = 2.4 (95% confidence interval, 1.3-4.5) to HR = 33 (95% confidence interval, 10-110) depending on the OME and time period. CONCLUSION: Patients who require opioids beyond 90 days after TKA warrant close follow-up.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Namba RS, Inacio MCS, Pratt NL, et al. Persistent Opioid Use Following Total Knee Arthroplasty: A Signal for Close Surveillance. J Arthroplasty. 2017. PMID: 28974377. doi:10.1016/j.arth.2017.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。